Pathologic myopia: where are we now?

Am J Ophthalmol. 2002 Nov;134(5):645-60. doi: 10.1016/s0002-9394(02)01883-4.

Abstract

Purpose: To describe current concepts and available treatments for pathologic myopia.

Design: Review of experimental and clinical studies.

Methods: The demography, natural history, medical and surgical treatments for choroidal neovascular membrane, vitreoretinal interface disorders and future strategies for pathologic myopia are reviewed.

Results: Several medical and surgical modalities are currently available to treat various complications of pathologic myopia. Macular translocation appears to stabilize or improve visual function in many eyes with choroidal neovascularization.

Conclusion: Newer strategies are emerging to better ameliorate or prevent the complications of pathologic myopia.

Publication types

  • Case Reports
  • Lecture

MeSH terms

  • Animals
  • Atrophy
  • Choroid / pathology
  • Choroidal Neovascularization / etiology
  • Choroidal Neovascularization / pathology
  • Choroidal Neovascularization / therapy
  • Female
  • Fluorescein Angiography
  • Humans
  • Laser Coagulation
  • Macular Degeneration / etiology
  • Macular Degeneration / pathology
  • Macular Degeneration / therapy
  • Male
  • Middle Aged
  • Myopia / complications*
  • Myopia / pathology*
  • Myopia / therapy
  • Photochemotherapy
  • Retina / pathology
  • Retina / transplantation
  • Retinal Perforations / etiology
  • Retinal Perforations / pathology
  • Retinal Perforations / therapy